申请人:Hoffmnn-La Roche Inc.
公开号:US20150141413A1
公开(公告)日:2015-05-21
The present invention provides a compound of formula I having BACE1 inhibitory activity, their manufacture, pharmaceutical compositions containing them and their use as therapeutically active substances. The active compounds of the present invention are useful in the therapeutic and/or prophylactic treatment of e.g. Alzheimer's disease.
本发明提供了一种具有BACE1抑制活性的I式化合物,其制造方法,含有它们的制药组合物以及它们作为治疗活性物质的用途。本发明的活性化合物在治疗和/或预防例如阿尔茨海默病等疾病方面是有用的。